Research Grade Tibulizumab
Product Specifications
Product Name Alternative
Bispecific, LY3090106, LY-3090106, LY3090106, CAS:1849636-24-3
Expression System
Mammalian Cells
Host
Humanized
Target
CTLA-8, CytotoxicT-lymphocyte-associatedantigen8, IL17, IL-17A, IL17A, CTLA8, IL-17, Interleukin-17A, BAFF, ZTNF4, BLYS, Tumornecrosisfactorligandsuperfamilymember13B, Dendriticcell-derivedTNF-likemolecule, TALL-1, TNF-andAPOL-relatedleukocyteexpressedligand1, BLyS, Blymphocytestimulator, TNFSF13B, CD257, TNFSF20, TALL1, B-cell-activatingfactor
Clonality
Monoclonal
Applications
ELISA, Bioactivity: FACS, Functional assay, Research in vivo
Purification
Protein A/G purified from cell culture supernatant.
Concentration
0.71mg/ml
Endotoxin
Please contact with the lab for this information.
Purity
>95% as determined by SDS-PAGE.
Form
Liquid
Buffer
0.01M PBS, pH7.4.
Storage Conditions
Use a manual defrost freezer and avoid repeated freeze-thaw cycles. Store at4°C short term (1-2weeks) . Store at-20°C 12 months. Store at -104°C long term.
Notes
For research use only. Not suitable for clinical or therapeutic use.
Buffer pH
0.01M PBS, pH7.4.
Species
Human
Isotype
IgG4-kappa-[scFv]2
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
TP720106XL 1 mg
beta Defensin 1 (DEFB1) (NM_005218) Human Recombinant Protein
Sign In for Pricing
View Details 
